SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-20-024337
Filing Date
2020-12-28
Accepted
2020-12-28 15:02:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 formsc13g.htm SC 13G 138351
2 ex1.htm EX-1 4073
  Complete submission text file 0001493152-20-024337.txt   144063
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Subject) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-80136 | Film No.: 201418182
SIC: 2834 Pharmaceutical Preparations

Mailing Address 150 EAST 52ND STREET SUITE 32001 NEW YORK NY 10022
Business Address 150 EAST 52ND STREET SUITE 32001 NEW YORK NY 10022 646-597-6995
PURA VIDA INVESTMENTS, LLC (Filed by) CIK: 0001590144 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G